# PROJECT_STATE — SBGlobal Plus
**Updated:** 2026-09-21 · **Checkpoint:** `DEV-COMMERCIAL-APPLY-EVIDENCE-GATE-001`

- Branch: `docs/architecture-branch-2`.
- Verified feature executable: `1704259d61c77937eaf866162ca67689dee3b714` / `c5656d68ddc50b480fec63117d267e8a0def1bd2`.
- Core **265/265 PASS**; PostgreSQL **61/61 PASS**; full DB bootstrap **46 migrations / 40 verification files PASS**.
- Next.js 15.5.25 production build: **PASS**; Database Verify: **PASS**.
- Feature-tree inventory: **389 blobs / 151 Markdown / 81 source / 57 test files**.
- RawSourceCorpus accepted blobs unchanged; `main` remains `3911590ff2020993ce51b32d7b091efd6f5f466f`.
- **9 Industries / 41 canonical MS / 181 registered Industry tables** remain the verified scope.
- ADR-001…ADR-020 and DD-001…DD-077 are contiguous with no duplicate definitions.
- DD-077 provides read-only persisted DD-066 apply-evidence consumption under existing compiler-role least privilege.
- Latest assessment, live Subscription/source/route, producer-owned route resolution, remediation provenance, fingerprint equality and NEXT_RENEWAL timing are fail-closed.
- DD-077 does not make evidence validation atomic with DD-065 publication.
- Concrete assessment evaluator, DD-066 write orchestration, Billing/payment/proration, Workflow approval and public `core.commercial.subscription.changePlan` remain unfinished.
- PR #2 remains OPEN DRAFT / unmerged.

Next: source-audit same-transaction DD-066 evidence validation inside DD-065 publication.

Evidence: `Registers/DEVELOPMENT_DD077_VERIFICATION_2026-09-21.md`.
